|
1
|
Bai Y, Lin H, Fang Z, Luo Q, Fang Y, Su Y,
Hu Q, Duan H, Chen F and Zhang ZY: Plasma microRNA-19a as a
potential biomarker for esophageal squamous cell carcinoma
diagnosis and prognosis. Biomark Med. 11:431–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao Z, Zheng X, Cao L and Liang N:
MicroRNA-539 inhibits the epithelial-mesenchymal transition of
esophageal cancer cells by twist-related protein 1-mediated
modulation of melanoma associated antigen A4. Oncol Res.
26:529–536. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cui XB, Peng H, Li RR, Mu JQ, Yang L, Li
N, Liu CX, Hu JM, Li SG, Wei Y, et al: MicroRNA-34a functions as a
tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh
esophageal squamous cell carcinoma. Oncotarget. 8:92454–92469.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fong LY, Taccioli C, Jing R, Smalley KJ,
Alder H, Jiang Y, Fadda P, Farber JL and Croce CM: MicroRNA
dysregulation and esophageal cancer development depend on the
extent of zinc dietary deficiency. Oncotarget. 7:10723–10738. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen M, Xia Y, Tan Y, Jiang G, Jin H and
Chen Y: Downregulation of microRNA-370 in esophageal squamous-cell
carcinoma is associated with cancer progression and promotes cancer
cell proliferation via upregulating PIN1. Gene. 661:68–77. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Z, Zhao L, Zhao F, Yang G and Wang J:
MicroRNA-26b regulates cancer proliferation migration and cell
cycle transition by suppressing TRAF5 in esophageal squamous cell
carcinoma. Am J Transl Res. 8:1957–1970. 2016.PubMed/NCBI
|
|
7
|
Dong W, Li B, Wang J, Song Y, Zhang Z, Fu
C and Zhang P: Diagnostic and predictive significance of serum
microRNA-7 in esophageal squamous cell carcinoma. Oncol Rep.
35:1449–1456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao X, Wang X, Cai K, Wang W, Ju Q, Yang
X, Wang H and Wu H: MicroRNA-127 is a tumor suppressor in human
esophageal squamous cell carcinoma through the regulation of
oncogene FMNL3. Eur J Pharmacol. 791:603–610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He W, Feng J, Zhang Y, Wang Y, Zang W and
Zhao G: microRNA-186 inhibits cell proliferation and induces
apoptosis in human esophageal squamous cell carcinoma by targeting
SKP2. Lab Invest. 96:317–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji HH, Hong L, Huang GL, Yin HX, Xu P, Luo
SY and Song JK: Association between microRNA-196a2 rs11614913,
microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms
and esophageal cancer risk: A meta-analysis. Meta Gene. 3:14–25.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu N, Song Y, Pang L and Chen Z: CRCT1
regulated by microRNA-520 g inhibits proliferation and induces
apoptosis in esophageal squamous cell cancer. Tumour Biol.
37:8271–8279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu Q, Liu Y, Wen C, Zhao Y, Jin S, Hu Y,
Wang F, Chen L, Zhang B, Wang W, et al: MicroRNA-1 inhibits
tumorigenicity of esophageal squamous cell carcinoma and enhances
sensitivity to gefitinib. Oncol Lett. 15:963–971. 2018.PubMed/NCBI
|
|
13
|
Bulibu J, Wang W, Tang Y, Li N and
Saifuding K: Association between polymorphisms in the promoter
region of microRNA-34b/c and the chemoradiotherapy efficacy for
locally advanced esophageal squamous cell carcinoma in Chinese Han
population. Pathol Oncol Res. 25:421–427. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harada K, Baba Y, Ishimoto T, Kosumi K,
Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J,
et al: Suppressor microRNA-145 is epigenetically regulated by
promoter hypermethylation in esophageal squamous cell carcinoma.
Anticancer Res. 35:4617–4624. 2015.PubMed/NCBI
|
|
15
|
Chan CM, Lai KK, Ng EK, Kiang MN, Kwok TW,
Wang HK, Chan KW, Law TT, Tong DK, Chan KT, et al: Serum
microRNA-193b as a promising biomarker for prediction of
chemoradiation sensitivity in esophageal squamous cell carcinoma
patients. Oncol Lett. 15:3273–3280. 2018.PubMed/NCBI
|
|
16
|
Dong S, Yin H, Dong C, Sun K, Lv P, Meng
W, Ming L and He F: Predictive value of plasma MicroRNA-216a/b in
the diagnosis of esophageal squamous cell carcinoma. Dis Markers.
2016:18570672016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan YX, Bian XH, Qian PD, Chen ZZ, Wen J,
Luo YH, Yan PW and Zhang Q: MicroRNA-125b inhibits cell
proliferation and induces cell apoptosis in esophageal squamous
cell carcinoma by targeting BMF. Oncol Rep. 40:61–72.
2018.PubMed/NCBI
|
|
18
|
Berry MF: Esophageal cancer: Staging
system and guidelines for staging and treatment. J Thorac Dis. 6
(Suppl 3):S289–S297. 2014.PubMed/NCBI
|
|
19
|
Liu L, Wang S, Chen R, Wu Y, Zhang B,
Huang S, Zhang J, Xiao F, Wang M and Liang Y: Myc induced
miR-144/451 contributes to the acquired imatinib resistance in
chronic myelogenous leukemia cell K562. Biochem Biophys Res Commun.
425:368–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whitman SP, Maharry K, Radmacher MD,
Becker H, Mrózek K, Margeson D, Holland KB, Wu YZ, Schwind S,
Metzeler KH, et al: FLT3 internal tandem duplication associates
with adverse outcome and gene- and microRNA-expression signatures
in patients 60 years of age or older with primary cytogenetically
normal acute myeloid leukemia: A Cancer and Leukemia Group B study.
Blood. 116:3622–3626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Z, Liu R, Liao J, Yang M, Pan E, Yin L
and Pu Y: Possible tumor suppressive role of the miR-144/451
cluster in esophageal carcinoma as determined by principal
component regression analysis. Mol Med Rep. 14:3805–3813. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu W, Hou W, Wu Z, Wang Y, Yi Y and Lin W:
miRNA-144 in the saliva is a genetic marker for early diagnosis of
esophageal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 33:1783–1786.
2013.(In Chinese). PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
25
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu C, Lv L, Peng J, Liu D, Wang X, Zhou Y
and Huo J: MicroRNA-375 suppresses esophageal cancer cell growth
and invasion by repressing metadherin expression. Oncol Lett.
13:4769–4775. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang ZQ, Cao Z, Liu C, Li R, Wang WD and
Wang XY: MiRNA-embedded ShRNAs for radiation-inducible LGMN
knockdown and the antitumor effects on breast cancer. PLoS One.
11:e01634462016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dong S, Yin H, Dong C, Sun K, Lv P, Meng
W, Ming L and He F: Corrigendum to ‘Predictive value of plasma
MicroRNA-216a/b in the diagnosis of esophageal squamous cell
carcinoma’. Dis Markers. 2017:34376792017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fong LY, Farber JL and Croce CM: Zinc
intake, microRNA dysregulation, and esophageal cancer. Aging
(Albany NY). 8:1161–1162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cui H, Zhang S, Zhou H and Guo L: Direct
downregulation of B-cell translocation gene 3 by microRNA-93 is
required for desensitizing esophageal cancer to radiotherapy. Dig
Dis Sci. 62:1995–2003. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan JY, Yang Y, Xie JY, Lu YL, Shi K and
Huang YQ: MicroRNA-144 mediates metabolic shift in ovarian cancer
cells by directly targeting Glut1. Tumour Biol. 37:6855–6860. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang J, Shi Y, Li H, Yang M and Liu G:
MicroRNA-144 acts as a tumor suppressor by targeting Rho-associated
coiled-coil containing protein kinase 1 in osteosarcoma cells. Mol
Med Rep. 12:4554–4559. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huo F, Zhang C, He H and Wang Y:
MicroRNA-144-3p inhibits proliferation and induces apoptosis of
human salivary adenoid carcinoma cells via targeting of mTOR.
Biotechnol Lett. 38:409–416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin J, Wang Y, Xu Y, Zhou X, Liu Y, Li X
and Wang J: MicroRNA-144 regulates cancer cell proliferation and
cell-cycle transition in acute lymphoblastic leukemia through the
interaction of FMN2. J Gene Med. 19:2017. View Article : Google Scholar
|
|
36
|
Li B, Zhang S, Shen H and Li C:
MicroRNA-144-3p suppresses gastric cancer progression by inhibiting
epithelial-to-mesenchymal transition through targeting PBX3.
Biochem Biophys Res Commun. 484:241–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li D, Li H, Yang Y and Kang L: Long
noncoding RNA urothelial carcinoma associated 1 promotes the
proliferation and metastasis of human lung tumor cells by
regulating MicroRNA-144. Oncol Res. 26:537–546. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin L, Zheng Y, Tu Y, Wang Z, Liu H, Lu X,
Xu L and Yuan J: MicroRNA-144 suppresses tumorigenesis and tumor
progression of astrocytoma by targeting EZH2. Hum Pathol.
46:971–980. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY and Fu L:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shao Y, Li P, Zhu ST, Yue JP, Ji XJ, Ma D,
Wang L, Wang YJ, Zong Y, Wu YD and Zhang ST: MiR-26a and miR-144
inhibit proliferation and metastasis of esophageal squamous cell
cancer by inhibiting cyclooxygenase-2. Oncotarget. 7:15173–15186.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ko YH, Domingo-Vidal M, Roche M, Lin Z,
Whitaker-Menezes D, Seifert E, Capparelli C, Tuluc M, Birbe RC,
Tassone P, et al: TP53-inducible glycolysis and apoptosis regulator
(TIGAR) metabolically reprograms carcinoma and stromal cells in
breast cancer. J Biol Chem. 291:26291–26303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu X, Liu C and Bao J: Hypoxia-induced
hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear
cell renal cell carcinoma. Mol Med Rep. 15:1373–1378. 2017.
View Article : Google Scholar : PubMed/NCBI
|
